<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032276/" ref="ordinalpos=4098&amp;ncbi_uid=6176687&amp;link_uid=PMC4032276" image-link="/pmc/articles/PMC4032276/figure/pone-0098185-g007/" class="imagepopup">Figure 7. Schematic diagram illustrating the proposed <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> involved in bupivacaine-induced WDR35 expression in Neuro2a cells..  From: Enhanced Expression of WD Repeat-Containing Protein 35 via CaMKK/AMPK Activation in Bupivacaine-Treated Neuro2a Cells. </a></div><br /><div class="p4l_captionBody"></div></div>